JACC -- van der Hoeven et al. 51 (6): 618 Figure IG3

Please click here to obtain permission to reproduce this image.

Click on image to view larger version.

Figure 3 Event Free and TVF Free Survival

(A) Kaplan-Meier estimates of survival free from any events among patients treated with BMS and those treated with SES. The event-free survival was significantly higher in the SES group than the BMS group (p = 0.01). (B) Kaplan-Meier estimates of survival free from target vessel failure (TVF) among patients treated with BMS and those treated with SES. The TVF free survival was significantly higher in the SES group than the BMS group (p = 0.02). Abbreviations as in Figure 1.